ArticleFrontiers in oncology2025

The nomogram of contrast-enhanced ultrasound-targeted fusion biopsy predicts the pathology upgrade in prostate cancer.

Jianhui Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.